CIK: 0001595851 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Apr 9, 2020
Total Value: $276M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 750,000 | $53.81M | 19.5% | — | — | Call | 78464A870 |
| — | MIRATI THERAPEUTICS INC | 400,000 | $16.97M | 6.2% | $33.00 | — | COM | 60468T105 |
| — | DICERNA PHARMACEUTICALS INC | 1,250,000 | $13.36M | 4.8% | $11.55 | — | COM | 253031108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 80,000 | $13.26M | 4.8% | $173.27 | 0.0% | COM | 92532F100 |
| — | IMMUNOMEDICS INC | 800,000 | $11.42M | 4.1% | $8.35 | — | Put | 452907108 |
| — | IMMUNOMEDICS INC | 800,000 | $11.42M | 4.1% | $8.35 | — | COM | 452907108 |
| — | RETROPHIN INC | 500,000 | $11.31M | 4.1% | $26.90 | — | COM | 761299106 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 275,000 | $10.17M | 3.7% | $37.40 | — | COM | G11196105 |
| ANAB | ANAPTYSBIO INC | 140,000 | $8.931M | 3.2% | $80.01 | -7.1% | COM | 032724106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 600,000 | $8.892M | 3.2% | $16.85 | -1.5% | COM | 77313F106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,000,000 | $8.85M | 3.2% | $9.64 | 0.0% | COM | 462260100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 425,000 | $8.394M | 3.0% | $16.62 | +21.0% | COM | 483497103 |
| ASND | ASCENDIS PHARMA A S | 125,000 | $7.831M | 2.8% | $49.12 | — | SPONSORED ADR | 04351P101 |
| SRPT | SAREPTA THERAPEUTICS INC | 70,000 | $7.639M | 2.8% | $78.35 | +59.6% | COM | 803607100 |
| — | OBSEVA SA | 550,000 | $6.963M | 2.5% | $11.87 | — | COM | H5861P103 |
| — | AUDENTES THERAPEUTICS INC | 300,000 | $6.396M | 2.3% | $21.32 | — | COM | 05070R104 |
| FOLD | AMICUS THERAPEUTICS INC | 650,000 | $6.227M | 2.3% | $10.99 | 0.0% | COM | 03152W109 |
| — | TRICIDA INC | 250,000 | $5.895M | 2.1% | $30.07 | — | COM | 89610F101 |
| FXF | INVESCO CURNCYSHS SWISS FRAN | 55,200 | $5.237M | 1.9% | $95.31 | — | SWISS FRANC | 46138R108 |
| — | ORCHARD THERAPEUTICS PLC | 300,000 | $4.719M | 1.7% | $15.73 | — | ADS | 68570P101 |
| VRAYQ | VIEWRAY INC | 750,000 | $4.553M | 1.7% | $6.99 | +7.3% | COM | 92672L107 |
| — | KADMON HLDGS INC | 2,000,000 | $4.16M | 1.5% | $3.85 | — | COM | 48283N106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 100,000 | $4.105M | 1.5% | $41.55 | — | COM | 37890U108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 500,000 | $4.035M | 1.5% | $6.72 | +15.8% | COM | 09058V103 |
| — | ZAFGEN INC | 750,000 | $3.713M | 1.3% | $11.49 | — | COM | 98885E103 |
| — | BIODELIVERY SCIENCES INTL IN | 1,000,000 | $3.7M | 1.3% | $2.94 | — | COM | 09060J106 |
| — | MOMENTA PHARMACEUTICALS INC | 325,000 | $3.588M | 1.3% | $11.04 | — | COM | 60877T100 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 85,000 | $3.489M | 1.3% | $41.55 | — | Put | 37890U108 |
| — | SAGE THERAPEUTICS INC | 30,000 | $2.874M | 1.0% | $141.26 | — | Call | 78667J108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 35,000 | $2.552M | 0.9% | $99.19 | -22.5% | COM | 02043Q107 |
| ARVN | ARVINAS INC | 175,000 | $2.249M | 0.8% | $16.46 | -3.6% | COM | 04335A105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 125,000 | $2.021M | 0.7% | $25.20 | -22.9% | COM | 004225108 |
| UROV | UROVANT SCIENCES LTD | 300,000 | $1.977M | 0.7% | $12.00 | — | SHS | G9381B108 |
| — | CATALYST BIOSCIENCES INC | 200,000 | $1.578M | 0.6% | $25.80 | — | COM NEW | 14888D208 |
| — | GENOCEA BIOSCIENCES INC | 3,525,000 | $1.011M | 0.4% | $0.86 | — | COM | 372427104 |
| — | INTRA CELLULAR THERAPIES INC | 79,400 | $904K | 0.3% | — | — | Call | 46116X101 |
| — | PROTEOSTASIS THERAPEUTICS IN | 190,000 | $616K | 0.2% | $3.24 | — | COM | 74373B109 |
| — | SAGE THERAPEUTICS INC | 3,300 | $316K | 0.1% | $141.26 | — | COM | 78667J108 |
| — | MOTUS GI HLDGS INC | 100,000 | $311K | 0.1% | $4.48 | — | COM | 62014P108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 900 | $101K | 0.0% | $175.60 | -11.9% | COM | 558868105 |